MEI Pharma Names New CFO

San Diego-based MEI Pharma, which is developing cancer treatments, said today that it has named Brian Drazba as its Chief Financial Officer. Drazba was most recently CFO of Heron Therapeutics, and also had served at ISTA Pharmaceuticals, Insight Health, and Arthur Andersen & Co. Drazba is replacing Thomas Zech, who the company says is retiring after four decades in the industry. Zech had been CFO since June of 2010.